3628 results

PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease

30 Aug 2022

Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona

Author

Elad Asher

Discover the new Evolut­™ PRO+ TAVI System

17 Jun 2021

New data from Optimize PRO interim analysis

From a design built on a proven platform1, the Evolut™ PRO+ system provides the performance and outcomes you need to help patients live life to the fullest.

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Author

Mirvat Alasnag

The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation

27 Aug 2023

Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial

Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.

Note the assumptions in this article are based on the presentation...

Author

Nicola Ryan

Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial

05 Mar 2023

Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Author

Luigi Biasco

NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

01 Sep 2024

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Author

Chiara De Biase

Author

Jacob Lønborg

Author

Ali Nazmi Calik

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase

Implantation of the Portico With FlexNav TAVI System in a patient with aortic stenosis, severe renal impairment, and diffuse iliac atherosclerosis

12 May 2020

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.